These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2164102)

  • 21. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
    Bhargava HN; Matwyshyn GA; Gudehithlu KP
    Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abstinence from U-50,488H, a kappa-opiate receptor agonist, decreases the binding of [3H]DPAT to 5-HT1A receptors in the hypothalamus of the rat.
    Reddy VP; Bhargava HN
    Neuropharmacology; 1992 Dec; 31(12):1243-9. PubMed ID: 1470300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Laorden ML; Milanés MV
    J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN; Gulati A; Rahmani NH
    Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a kappa-receptor agonist, U-50,488H, on the release of endogenous brain dopamine.
    Clow DW; Jhamandas K
    Can J Physiol Pharmacol; 1988 Feb; 66(2):128-33. PubMed ID: 2836044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
    Thorat SN; Veeranna ; Reddy PL; Bhargava HN
    Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of free intracellular calcium levels [(Ca++)i] in brain and spinal cord of morphine-tolerant rats and mice.
    Welch SP; Bass PP
    Pharmacol Biochem Behav; 1995 May; 51(1):57-63. PubMed ID: 7617733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1-13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    Brain Res; 1993 Jan; 600(1):151-5. PubMed ID: 8093675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats.
    Tejwani GA; Rattan AK; Koo KL; Matwyshyn GA; Bhargava HN
    Pharmacology; 1994 Apr; 48(4):216-25. PubMed ID: 8177908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat.
    Gulati A; Ramarao P; Bhargava HN
    Pharmacology; 1989; 39(3):145-53. PubMed ID: 2587620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse.
    Piercey MF; Lahti RA; Schroeder LA; Einspahr FJ; Barsuhn C
    Life Sci; 1982 Sep 20-27; 31(12-13):1197-200. PubMed ID: 6292608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.